Outcomes of Restrictive Cardiomyopathy Following LVAD Placement: An IMACS Analysis

Outcomes of patients with advanced heart failure (HF) due to restrictive cardiomyopathy (RCM) remain unfavorable in spite of advances in HF therapies. Left ventricular assist devices (LVADs) are a standard therapeutic option for patients with advanced HF, however there is limited data to support LVAD implantation in these patients. The purpose of this study was to examine outcomes in patients with end-stage RCM following LVAD implantation when compared with those with dilated cardiomyopathies (DCM).

Source: Journal of Cardiac Failure - September 30, 2020 Category: Cardiology Authors: Chris Chaudhary, Michael Yaoyao Yin, Elizabeth Dranow, Stavros G. Drakos, Josef Stehlik, Edward M. Gilbert, Kevin S. Shah, Line Kemeyou, Omar Wever-Pinzon, Stephen H. McKellar, Craig H. Selzman, James C. Fang, Jose Nativi-Nicolau Tags: 436 Source Type: research